Mr. Denis Boucher reports

THERATECHNOLOGIES HIRES NEW CHIEF FINANCIAL OFFICER

Theratechnologies Inc. has hired Philippe Dubuc as senior vice-president and chief financial officer.

"After the first full year of marketing EGRIFTA on our own in the United States, we are now entering the next phase of our business strategy. As senior VP and CFO, Philippe will play a crucial role in increasing our relationships with current and future investors. Equally important, he will lead our efforts in the identification of potential product acquisitions and in-licensing opportunities that could maximize the return on our infrastructure and fit within our distribution network," said Luc Tanguay, president and chief executive officer of Theratechnologies.

"Our company is well placed to further exploit its infrastructure particularly in the U.S., and also to support the human immunodeficiency virus community," added Mr. Tanguay.

Mr. Dubuc brings more than 25 years of experience in investment banking in the health care sector and in management. He started his career as a management consultant at Groupe Secor, a well-known Quebec-based consulting firm which is now part of KPMG.

He then served as managing director of investment banking at National Bank Financial. In this role, he headed the health care group and was involved in numerous financing and merger and acquisition transactions. He later founded a manufacturing company which he sold after seven years of successful operations.

Mr. Dubuc holds an MBA from McGill University and a BComm from Concordia University.